<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Susceptibility to infections in persons with diabetes mellitus</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Susceptibility to infections in persons with diabetes mellitus</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Susceptibility to infections in persons with diabetes mellitus</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Amy C Weintrob, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Daniel J Sexton, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sandra Nelson, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Keri K Hall, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Feb 23, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>It is widely accepted by both the medical profession and the general public that diabetics have an increased propensity to develop infections. Although several epidemiologic studies have shown that diabetics receive treatment for infections more often than non-diabetics, the magnitude of the effect of diabetes on the risk of infection remains an active research question.</p><p>Host- and organism-specific factors that may explain why people with DM are more susceptible to particular infections will be reviewed here. The clinical features, diagnosis, and treatment of specific infections that appear either to be more prevalent in diabetics or to have unique features when they occur in diabetics are discussed separately. These infections include:</p><p class="bulletIndent1"><span class="glyph">●</span>Foot infections (see  <a class="medical medical_review" href="/d/html/7651.html" rel="external">"Clinical manifestations, diagnosis, and management of diabetic infections of the lower extremities"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Urinary tract infections, including fungal infections (see  <a class="medical medical_review" href="/d/html/8066.html" rel="external">"Emphysematous urinary tract infections"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Superficial fungal infections, such as oral candidiasis, onychomycosis, and intertrigo (see  <a class="medical medical_review" href="/d/html/2427.html" rel="external">"Esophageal candidiasis in adults"</a> and  <a class="medical medical_review" href="/d/html/4034.html" rel="external">"Onychomycosis: Epidemiology, clinical features, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/115366.html" rel="external">"Intertrigo"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Mucormycosis (see  <a class="medical medical_review" href="/d/html/2465.html" rel="external">"Mucormycosis (zygomycosis)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Malignant external otitis (see  <a class="medical medical_review" href="/d/html/3413.html" rel="external">"Malignant (necrotizing) external otitis"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Emphysematous cholecystitis (see  <a class="medical medical_review" href="/d/html/666.html" rel="external">"Acute calculous cholecystitis: Clinical features and diagnosis"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pyomyositis, which is a primary bacterial infection of skeletal muscle characterized by the formation of one or more intramuscular abscesses (see  <a class="medical medical_review" href="/d/html/7669.html" rel="external">"Primary pyomyositis"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Necrotizing fasciitis, usually due to mixed aerobic and anaerobic infection (see  <a class="medical medical_review" href="/d/html/7662.html" rel="external">"Necrotizing soft tissue infections"</a>)</p><p></p><p class="headingAnchor" id="H2949879143"><span class="h1">RISK OF INFECTION</span><span class="headingEndMark"> — </span>Most studies support an increased risk of infection among patients with diabetes mellitus compared with the general population, although the magnitude of this risk is uncertain [<a href="#rid1">1-7</a>]. As examples:</p><p class="bulletIndent1"><span class="glyph">●</span>In a matched cohort study using a Canadian electronic medical record-based surveillance system, the odds of any infection were higher among 1779 patients with diabetes (22 percent on insulin) compared with 11,066 matched controls, after controlling for potential confounders (adjusted odds ratio 1.21, 95% CI 1.07-1.37) [<a href="#rid1">1</a>]. In particular, diabetes mellitus was associated with skin and soft tissue infections followed by genitourinary, gastrointestinal, and respiratory infections; there was no association with head and neck, musculoskeletal, and viral infections.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In another retrospective cohort study using a large primary care database in England, the incidence rate ratio (IRR) for any infection was higher among 5863 patients with type 1 diabetes mellitus (IRR 1.66, 95% CI 1.59-1.74) and 96,930 with type 2 diabetes mellitus (1.47, 95% CI 1.46-1.49) compared with age, sex, and practice-matched controls (n = 11,696 for type 1 and n = 191,822 for type 2) [<a href="#rid2">2</a>]. The IRRs for type 1 diabetes mellitus were highest for bone and joint infections, endocarditis, meningitis, and sepsis. The IRRs for type 2 diabetes mellitus were highest for bone and joint infections, candidiasis, sepsis, and cellulitis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>One study from the Netherlands assessed the number of infections in treated type 2 diabetics cared for in a general practice during a two-year period [<a href="#rid4">4</a>]. Four hundred and fifty-eight infections occurred in 193 patients for a mean of 2.4 infections per patient (± 1.9). </p><p></p><p>Most, but not all studies suggest that the risk of infection in diabetes mellitus is associated with hyperglycemia or lack of diabetes mellitus control [<a href="#rid4">4,8,9</a>]. In particular, diabetes mellitus and postoperative hyperglycemia have been strongly associated with surgical site infections (SSIs) [<a href="#rid9">9-14</a>]. As an example, in a multivariable logistic regression analysis of 49,817 patients undergoing major vascular surgery, diabetes mellitus was significantly associated with SSI (OR 1.3, 95% CI 1.2-1.4) [<a href="#rid14">14</a>]. Additionally, in a study involving 1561 patients undergoing general and vascular surgery, postoperative hyperglycemia was the sole independent risk factor for SSI among general surgery patients after multivariate adjustment for other factors, such as age, emergency status, American Society of Anesthesiologists preoperative classification score, and operative time [<a href="#rid13">13</a>]. There appeared to be a linear relationship between the degree of elevation in postoperative glucose concentrations and the risk of an SSI. The study's retrospective design, the absence of postoperative glucose level measurements on approximately a quarter of the patients, and the lack of association between hyperglycemia and SSI among vascular surgery patients lower confidence in the results. However, they are generally consistent with other observational data, including a prospective study of 1000 patients undergoing cardiothoracic surgical procedures, in whom increasing levels of postoperative hyperglycemia (in patients with or without diabetes mellitus) were increasingly associated with risk of SSI [<a href="#rid10">10</a>].</p><p>Accordingly, several studies have suggested that improved glucose control during the operative and perioperative period can reduce the risk of postoperative infections following cardiac surgery [<a href="#rid15">15,16</a>]. In a meta-analysis of four randomized trials plus six cohort studies, glycemic control with a continuous insulin infusion to maintain glucose levels ≤200 mg/dL lowered SSI rates following cardiac surgery compared with subcutaneous insulin [<a href="#rid16">16</a>]. (See  <a class="medical medical_review" href="/d/html/1753.html" rel="external">"Perioperative management of blood glucose in adults with diabetes mellitus", section on 'Glucose management'</a>.)</p><p>It is likely that the association between diabetes mellitus and SSIs is related to the deleterious effect of hyperglycemia on chemotaxis, phagocytosis, and adherence of granulocytes. (See  <a class="medical medical_review" href="/d/html/112216.html" rel="external">"Risk factors for impaired wound healing and wound complications", section on 'Diabetes'</a>.)</p><p>Diabetes mellitus has also been associated with worse outcomes with infections such as bacteremia and endocarditis [<a href="#rid17">17-19</a>]. </p><p class="headingAnchor" id="H3"><span class="h1">HOST FACTORS</span><span class="headingEndMark"> — </span>Host-specific factors that are thought to predispose diabetic patients to infection include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Hyperglycemia-related impairment of the immune response</p><p class="bulletIndent1"><span class="glyph">●</span>Vascular insufficiency</p><p class="bulletIndent1"><span class="glyph">●</span>Sensory peripheral neuropathy</p><p class="bulletIndent1"><span class="glyph">●</span>Autonomic neuropathy</p><p class="bulletIndent1"><span class="glyph">●</span>Skin and mucosal colonization with pathogens such as <em>Staphylococcus aureus</em> and <em>Candida</em> species</p><p></p><p class="headingAnchor" id="H4"><span class="h2">Hyperglycemia-related impairment of immune response</span><span class="headingEndMark"> — </span>Neutrophil chemotaxis and adherence to vascular endothelium, phagocytosis, intracellular bactericidal activity, opsonization, and cell-mediated immunity are all depressed in diabetics with hyperglycemia [<a href="#rid20">20-22</a>]. Investigations to identify the mechanisms of immune impairment have noted the following findings:</p><p class="bulletIndent1"><span class="glyph">●</span>Release of tumor necrosis factor (TNF)-alpha and interleukin (IL)-1-beta from lipopolysaccharide-stimulated macrophages is reduced in diabetic mice compared with control mice [<a href="#rid23">23</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The level of macrophage inflammatory protein 2, a mediator of lung neutrophil recruitment, is significantly decreased in diabetic compared with control mice [<a href="#rid24">24</a>]. The deficiency causes a delay in neutrophil recruitment in the lungs.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hyperglycemia impairs opsonophagocytosis by diverting nicotinamide adenine dinucleotide phosphate from superoxide production into the aldose reductase-dependent polyol pathway [<a href="#rid25">25</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Diabetic mice with a bacterial infection of the scalp had greater than twofold induction of genes that directly or indirectly induce apoptosis compared with normoglycemic controls [<a href="#rid26">26</a>]. Blocking apoptosis allows for a significant improvement in wound healing and bone growth.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Methylglyoxal-glycation, which is a major pathway of glycemic damage in diabetics, inhibits production of IL-10 from myeloid cells as well as interferon-gamma and TNF-alpha from T cells; it also reduces major histocompatibility complex class I expression on the surface of myeloid cells [<a href="#rid27">27</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>High glucose concentrations competitively inhibit binding of oligosaccharides by C-type lectin; such binding is necessary for many functions of the immune system [<a href="#rid28">28</a>].</p><p></p><p>There has been substantial interest in studying the effects of glucose control in critically ill nondiabetic patients. This is discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/1600.html" rel="external">"Glycemic control in critically ill adult and pediatric patients"</a>.)</p><p class="headingAnchor" id="H5"><span class="h2">Vascular insufficiency</span><span class="headingEndMark"> — </span>Vascular disease is common in diabetes. When present, vascular insufficiency may result in local tissue ischemia that in turn enhances the growth of microaerophilic and anaerobic organisms while simultaneously depressing the oxygen-dependent bactericidal functions of leukocytes. Vascular disease related to diabetes may also impair the local inflammatory response and the absorption of antibiotics.</p><p class="headingAnchor" id="H6"><span class="h2">Sensory peripheral neuropathy</span><span class="headingEndMark"> — </span>Minor local trauma in patients with diabetes-associated peripheral neuropathy may result in skin ulcers, which, in turn, lead to diabetic foot infections. Skin lesions in such patients are often either unnoticed or ignored until infection occurs.</p><p class="headingAnchor" id="H7"><span class="h2">Autonomic neuropathy</span><span class="headingEndMark"> — </span>Patients with diabetes-associated autonomic neuropathy may develop urinary retention and stasis that, in turn, predispose them to develop urinary tract infections.</p><p class="headingAnchor" id="H8"><span class="h2">Increased skin and mucosal colonization</span><span class="headingEndMark"> — </span>Patients with diabetes, particularly those who inject insulin daily, often have asymptomatic nasal and skin colonization with <em>S. aureus</em>. Furthermore, according to an analysis of data from the National Health and Nutrition Examination Survey (NHANES) collected between 2001 and 2002, diabetic patients who are colonized with <em>S. aureus</em> are more likely to have a methicillin-resistant <em>S. aureus</em> isolate than a susceptible one (odds ratio 2.6, 95% CI 1.1-6.1) [<a href="#rid29">29</a>]. Colonization may predispose to cutaneous or incisional staphylococcal infections as well as transient bacteremia, which may then result in infection at distant sites such as damaged muscle.</p><p>Mucosal colonization with <em>Candida albicans</em> is also common. Women with diabetes who have poor glycemic control are more prone to vulvovaginal candidiasis than euglycemic women [<a href="#rid30">30,31</a>]. In particular, women with type 2 diabetes appear prone to non-albicans <em>Candida</em> species [<a href="#rid32">32</a>]. (See  <a class="medical medical_review" href="/d/html/5452.html" rel="external">"Candida vulvovaginitis: Clinical manifestations and diagnosis", section on 'Risk factors'</a>.)</p><p class="headingAnchor" id="H10"><span class="h1">ORGANISM-SPECIFIC FACTORS</span><span class="headingEndMark"> — </span>There are several organism-specific factors that predispose diabetics to infection.</p><p class="headingAnchor" id="H11"><span class="h2">Candida albicans</span><span class="headingEndMark"> — </span>Glucose-inducible proteins promote adhesion of <em>Candida albicans</em> to buccal or vaginal epithelium. This adhesion, in turn, impairs phagocytosis, giving the organism an advantage over the host [<a href="#rid22">22</a>].</p><p class="headingAnchor" id="H12"><span class="h2">Rhizopus species</span><span class="headingEndMark"> — </span>Ketone reductases allow <em>Rhizopus</em> spp, which cause mucormycosis, to thrive in high glucose, acidic conditions typically present in diabetic patients with ketoacidosis [<a href="#rid33">33</a>]. (See  <a class="medical medical_review" href="/d/html/2465.html" rel="external">"Mucormycosis (zygomycosis)"</a>.)</p><p class="headingAnchor" id="H29081675"><span class="h2">Burkholderia pseudomallei</span><span class="headingEndMark"> — </span>Diabetes is strongly associated with the risk of acquiring melioidosis in endemic areas. It is the single most common risk factor in patients who develop this infection. One of multiple reasons for this propensity is the fact that macrophage killing of <em>Burkholderia pseudomallei</em> is impaired in diabetic patients [<a href="#rid34">34</a>]. Drugs such as <a class="drug drug_general" data-topicid="8494" href="/d/drug information/8494.html" rel="external">glyburide</a> are associated with reduced mortality in patients with melioidosis, and glyburide reduces bacterial dissemination of <em>B. pseudomallei</em> in an experimental mouse model [<a href="#rid35">35-37</a>]. (See  <a class="medical medical_review" href="/d/html/3146.html" rel="external">"Melioidosis: Epidemiology, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/3136.html" rel="external">"Melioidosis: Treatment and prevention"</a>.)</p><p class="headingAnchor" id="H613679517"><span class="h2">Uropathogenic Escherichia coli</span><span class="headingEndMark"> — </span>Advanced glycation end products (AGEs) accumulate in diabetics over time. In a mouse model, AGEs enhance the binding of uropathogenic <em>Escherichia coli</em> isolates to the bladder urothelium, possibly increasing the susceptibility of diabetics to lower urinary tract infections with this organism [<a href="#rid38">38</a>].</p><p class="headingAnchor" id="H540090896"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, “The Basics” and “Beyond the Basics.” The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on “patient info” and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/83961.html" rel="external">"Patient education: Diabetes and infections (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H5153869"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span>It is widely accepted that diabetics have an increased propensity to develop infections. Despite a number of both systemic and local host factors that can contribute to infections, whether diabetics truly are at greater risk for infection and the magnitude of the effect of diabetes on the risk of infection remain active questions. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Most studies indicate that patients with diabetes mellitus have a higher risk of infection compared with the general population. In particular, an association between diabetes mellitus (particularly with postoperative hyperglycemia) and surgical site infection (SSI) is relatively well established. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Host-specific factors that are thought to predispose diabetic patients to infection include the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hyperglycemia-related impairment of the immune response</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Vascular insufficiency</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Sensory peripheral neuropathy</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Autonomic neuropathy</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Skin and mucosal colonization with pathogens such as <em>Staphylococcus aureus</em> and <em>Candida </em>species (see <a class="local">'Host factors'</a> above)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Neutrophil chemotaxis and adherence to vascular endothelium, phagocytosis, intracellular bactericidal activity, opsonization, and cell-mediated immunity are all depressed in diabetics with hyperglycemia. (See <a class="local">'Hyperglycemia-related impairment of immune response'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Vascular disease is common in diabetes. When present, vascular insufficiency may result in local tissue ischemia that, in turn, enhances the growth of microaerophilic and anaerobic organisms while simultaneously depressing the oxygen-dependent bactericidal functions of leukocytes. Vascular disease related to diabetes may also impair the local inflammatory response and the absorption of antibiotics. (See <a class="local">'Vascular insufficiency'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Minor local trauma in patients with diabetes-associated peripheral neuropathy may result in skin ulcers, which, in turn, lead to diabetic foot infections. Skin lesions in such patient are often either unnoticed or ignored until infection occurs. (See <a class="local">'Sensory peripheral neuropathy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with diabetes-associated autonomic neuropathy may develop urinary retention and stasis that, in turn, predispose them to develop urinary tract infections. (See <a class="local">'Autonomic neuropathy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with diabetes, particularly those who inject insulin daily, often have asymptomatic nasal and skin colonization with <em>S. aureus</em>. Furthermore, diabetic patients who are colonized with <em>S. aureus</em> are more likely to have a methicillin-resistant <em>S. aureus</em> isolate than a susceptible one. Colonization may predispose diabetic patients to cutaneous or incisional staphylococcal infections as well as transient bacteremia, which may then result in infection at distant sites such as damaged muscle. (See <a class="local">'Increased skin and mucosal colonization'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Women with diabetes who have poor glycemic control are more prone to vulvovaginal candidiasis than euglycemic women. (See <a class="local">'Increased skin and mucosal colonization'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>There are several organism-specific factors that predispose diabetics to infection:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Glucose-inducible proteins promote adhesion of <em>Candida albicans</em> to buccal or vaginal epithelium. This adhesion, in turn, impairs phagocytosis, giving the organism an advantage over the host.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Ketone reductases allow <em>Rhizopus</em> spp, which cause mucormycosis, to thrive in high glucose, acidic conditions typically present in diabetic patients with ketoacidosis. (See <a class="local">'Organism-specific factors'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Abu-Ashour W, Twells LK, Valcour JE, Gamble JM. Diabetes and the occurrence of infection in primary care: a matched cohort study. BMC Infect Dis 2018; 18:67.</a></li><li><a class="nounderline abstract_t">Carey IM, Critchley JA, DeWilde S, et al. Risk of Infection in Type 1 and Type 2 Diabetes Compared With the General Population: A Matched Cohort Study. Diabetes Care 2018; 41:513.</a></li><li><a class="nounderline abstract_t">Mor A, Berencsi K, Nielsen JS, et al. Rates of Community-based Antibiotic Prescriptions and Hospital-treated Infections in Individuals With and Without Type 2 Diabetes: A Danish Nationwide Cohort Study, 2004-2012. Clin Infect Dis 2016; 63:501.</a></li><li><a class="nounderline abstract_t">Bartelink ML, Hoek L, Freriks JP, Rutten GE. Infections in patients with type 2 diabetes in general practice. Diabetes Res Clin Pract 1998; 40:15.</a></li><li><a class="nounderline abstract_t">Marelli D, Laks H, Patel B, et al. Heart transplantation in patients with diabetes mellitus in the current era. J Heart Lung Transplant 2003; 22:1091.</a></li><li><a class="nounderline abstract_t">Thomas MC, Mathew TH, Russ GR, et al. Early peri-operative glycaemic control and allograft rejection in patients with diabetes mellitus: a pilot study. Transplantation 2001; 72:1321.</a></li><li><a class="nounderline abstract_t">Marchant MH Jr, Viens NA, Cook C, et al. The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. J Bone Joint Surg Am 2009; 91:1621.</a></li><li><a class="nounderline abstract_t">Estrada CA, Young JA, Nifong LW, Chitwood WR Jr. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg 2003; 75:1392.</a></li><li><a class="nounderline abstract_t">Martin ET, Kaye KS, Knott C, et al. Diabetes and Risk of Surgical Site Infection: A Systematic Review and Meta-analysis. Infect Control Hosp Epidemiol 2016; 37:88.</a></li><li><a class="nounderline abstract_t">Latham R, Lancaster AD, Covington JF, et al. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol 2001; 22:607.</a></li><li><a class="nounderline abstract_t">Golden SH, Peart-Vigilance C, Kao WH, Brancati FL. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care 1999; 22:1408.</a></li><li><a class="nounderline abstract_t">Guvener M, Pasaoglu I, Demircin M, Oc M. Perioperative hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting. Endocr J 2002; 49:531.</a></li><li><a class="nounderline abstract_t">Ata A, Lee J, Bestle SL, et al. Postoperative hyperglycemia and surgical site infection in general surgery patients. Arch Surg 2010; 145:858.</a></li><li><a class="nounderline abstract_t">Wiseman JT, Fernandes-Taylor S, Barnes ML, et al. Predictors of surgical site infection after hospital discharge in patients undergoing major vascular surgery. J Vasc Surg 2015; 62:1023.</a></li><li><a class="nounderline abstract_t">Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999; 67:352.</a></li><li><a class="nounderline abstract_t">Boreland L, Scott-Hudson M, Hetherington K, et al. The effectiveness of tight glycemic control on decreasing surgical site infections and readmission rates in adult patients with diabetes undergoing cardiac surgery: A systematic review. Heart Lung 2015; 44:430.</a></li><li><a class="nounderline abstract_t">Haug JB, Harthug S, Kalager T, et al. Bloodstream infections at a Norwegian university hospital, 1974-1979 and 1988-1989: changing etiology, clinical features, and outcome. Clin Infect Dis 1994; 19:246.</a></li><li><a class="nounderline abstract_t">Chirillo F, Bacchion F, Pedrocco A, et al. Infective endocarditis in patients with diabetes mellitus. J Heart Valve Dis 2010; 19:312.</a></li><li><a class="nounderline abstract_t">Kanafani ZA, Kourany WM, Fowler VG Jr, et al. Clinical characteristics and outcomes of diabetic patients with Staphylococcus aureus bacteremia and endocarditis. Eur J Clin Microbiol Infect Dis 2009; 28:1477.</a></li><li><a class="nounderline abstract_t">Delamaire M, Maugendre D, Moreno M, et al. Impaired leucocyte functions in diabetic patients. Diabet Med 1997; 14:29.</a></li><li><a class="nounderline abstract_t">Llorente L, De La Fuente H, Richaud-Patin Y, et al. Innate immune response mechanisms in non-insulin dependent diabetes mellitus patients assessed by flow cytoenzymology. Immunol Lett 2000; 74:239.</a></li><li><a class="nounderline abstract_t">Hostetter MK. Handicaps to host defense. Effects of hyperglycemia on C3 and Candida albicans. Diabetes 1990; 39:271.</a></li><li><a class="nounderline abstract_t">Zykova SN, Jenssen TG, Berdal M, et al. Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice. Diabetes 2000; 49:1451.</a></li><li><a class="nounderline abstract_t">Amano H, Yamamoto H, Senba M, et al. Impairment of endotoxin-induced macrophage inflammatory protein 2 gene expression in alveolar macrophages in streptozotocin-induced diabetes in mice. Infect Immun 2000; 68:2925.</a></li><li><a class="nounderline abstract_t">Mazade MA, Edwards MS. Impairment of type III group B Streptococcus-stimulated superoxide production and opsonophagocytosis by neutrophils in diabetes. Mol Genet Metab 2001; 73:259.</a></li><li><a class="nounderline abstract_t">Al-Mashat HA, Kandru S, Liu R, et al. Diabetes enhances mRNA levels of proapoptotic genes and caspase activity, which contribute to impaired healing. Diabetes 2006; 55:487.</a></li><li><a class="nounderline abstract_t">Price CL, Hassi HO, English NR, et al. Methylglyoxal modulates immune responses: relevance to diabetes. J Cell Mol Med 2010; 14:1806.</a></li><li><a class="nounderline abstract_t">Ilyas R, Wallis R, Soilleux EJ, et al. High glucose disrupts oligosaccharide recognition function via competitive inhibition: a potential mechanism for immune dysregulation in diabetes mellitus. Immunobiology 2011; 216:126.</a></li><li><a class="nounderline abstract_t">Graham PL 3rd, Lin SX, Larson EL. A U.S. population-based survey of Staphylococcus aureus colonization. Ann Intern Med 2006; 144:318.</a></li><li><a class="nounderline abstract_t">Donders GG. Lower Genital Tract Infections in Diabetic Women. Curr Infect Dis Rep 2002; 4:536.</a></li><li><a class="nounderline abstract_t">de Leon EM, Jacober SJ, Sobel JD, Foxman B. Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes. BMC Infect Dis 2002; 2:1.</a></li><li><a class="nounderline abstract_t">Ray D, Goswami R, Banerjee U, et al. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis. Diabetes Care 2007; 30:312.</a></li><li><a class="nounderline abstract_t">Ferguson BJ. Mucormycosis of the nose and paranasal sinuses. Otolaryngol Clin North Am 2000; 33:349.</a></li><li><a class="nounderline abstract_t">Hodgson KA, Morris JL, Feterl ML, et al. Altered macrophage function is associated with severe Burkholderia pseudomallei infection in a murine model of type 2 diabetes. Microbes Infect 2011; 13:1177.</a></li><li><a class="nounderline abstract_t">Wiersinga WJ, Currie BJ, Peacock SJ. Melioidosis. N Engl J Med 2012; 367:1035.</a></li><li><a class="nounderline abstract_t">Koh GC, Weehuizen TA, Breitbach K, et al. Glyburide reduces bacterial dissemination in a mouse model of melioidosis. PLoS Negl Trop Dis 2013; 7:e2500.</a></li><li><a class="nounderline abstract_t">Koh GC, Maude RR, Schreiber MF, et al. Glyburide is anti-inflammatory and associated with reduced mortality in melioidosis. Clin Infect Dis 2011; 52:717.</a></li><li><a class="nounderline abstract_t">Ozer A, Altuntas CZ, Izgi K, et al. Advanced glycation end products facilitate bacterial adherence in urinary tract infection in diabetic mice. Pathog Dis 2015; 73.</a></li></ol></div><div id="topicVersionRevision">Topic 2739 Version 24.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29402218" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Diabetes and the occurrence of infection in primary care: a matched cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29330152" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Risk of Infection in Type 1 and Type 2 Diabetes Compared With the General Population: A Matched Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27353662" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Rates of Community-based Antibiotic Prescriptions and Hospital-treated Infections in Individuals With and Without Type 2 Diabetes: A Danish Nationwide Cohort Study, 2004-2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9699086" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Infections in patients with type 2 diabetes in general practice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14550818" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Heart transplantation in patients with diabetes mellitus in the current era.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11602863" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Early peri-operative glycaemic control and allograft rejection in patients with diabetes mellitus: a pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19571084" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12735552" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26503187" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Diabetes and Risk of Surgical Site Infection: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11776345" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10480501" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12507271" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Perioperative hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20855756" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Postoperative hyperglycemia and surgical site infection in general surgery patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26143662" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Predictors of surgical site infection after hospital discharge in patients undergoing major vascular surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10197653" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26138777" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : The effectiveness of tight glycemic control on decreasing surgical site infections and readmission rates in adult patients with diabetes undergoing cardiac surgery: A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7986895" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Bloodstream infections at a Norwegian university hospital, 1974-1979 and 1988-1989: changing etiology, clinical features, and outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20583393" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Infective endocarditis in patients with diabetes mellitus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19730900" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Clinical characteristics and outcomes of diabetic patients with Staphylococcus aureus bacteremia and endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9017350" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Impaired leucocyte functions in diabetic patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11064109" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Innate immune response mechanisms in non-insulin dependent diabetes mellitus patients assessed by flow cytoenzymology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2407580" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Handicaps to host defense. Effects of hyperglycemia on C3 and Candida albicans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10969828" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10768990" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Impairment of endotoxin-induced macrophage inflammatory protein 2 gene expression in alveolar macrophages in streptozotocin-induced diabetes in mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11461193" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Impairment of type III group B Streptococcus-stimulated superoxide production and opsonophagocytosis by neutrophils in diabetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16443785" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Diabetes enhances mRNA levels of proapoptotic genes and caspase activity, which contribute to impaired healing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19538479" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Methylglyoxal modulates immune responses: relevance to diabetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20674073" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : High glucose disrupts oligosaccharide recognition function via competitive inhibition: a potential mechanism for immune dysregulation in diabetes mellitus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16520472" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : A U.S. population-based survey of Staphylococcus aureus colonization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12433331" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Lower Genital Tract Infections in Diabetic Women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11835694" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17259500" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10736409" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Mucormycosis of the nose and paranasal sinuses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21835260" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Altered macrophage function is associated with severe Burkholderia pseudomallei infection in a murine model of type 2 diabetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22970946" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Melioidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24147174" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Glyburide reduces bacterial dissemination in a mouse model of melioidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21293047" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Glyburide is anti-inflammatory and associated with reduced mortality in melioidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25986378" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Advanced glycation end products facilitate bacterial adherence in urinary tract infection in diabetic mice.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
